CenterWatch

Amyloidosis Clinical Trials

A listing of Amyloidosis medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

Alabama

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Arizona

Phoenix Arizona 85054

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Phoenix Arizona 85054

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Phoenix Arizona 85054

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Arkansas

UPDATED

Little Rock Arkansas

Patients are needed to participate in a clinical research study to evaluate Familial Amyloidotic Cardiomyopathy (FAC)

California

UPDATED

Bakersfield California

Patients are needed to participate in a clinical research study to evaluate Familial Amyloidotic Cardiomyopathy (FAC)

UPDATED

La Mesa California

A Phase 3 clinical study for patients with TTR-mediated Amyloidosis

UPDATED

Los Angeles California

Patients are needed to participate in a clinical research study to evaluate Familial Amyloidotic Cardiomyopathy (FAC)

UPDATED

Orange California

A Phase 3 clinical study for patients with TTR-mediated Amyloidosis

UPDATED

San Francisco California

Patients are needed to participate in a clinical research study to evaluate Familial Amyloidotic Cardiomyopathy (FAC)

View More ▼

UPDATED

Torrance California

Patients are needed to participate in a clinical research study to evaluate Familial Amyloidotic Cardiomyopathy (FAC)

Duarte California 91010

A Phase 1 clinical study for patients with Amyloidosis or Systemic Light-Chain Amyloidosis

La Jolla California 92037

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

La Jolla California 92037-7411

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

La Jolla California 92037-0990

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

La Jolla California 92037-0620

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Los Angeles California

A clinical trial to evaluate treatments for patients with Relapsed or Refractory Systemic Light Chain Amyloidosis

Orange California 92868

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Orange California 92868

A clinical trial seeking patients for a research study for the treatment of Familial Amyloid Polyneuropathy

Palo Alto California 94305

A clinical trial to evaluate treatments using NEOD001 for patients with Primary Amyloidosis

San Francisco California 94117

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

San Francisco California 94143

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

San Francisco California 94143

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Stanford California 94305

A Phase 1 clinical study for patients with Amyloidosis or Systemic Light-Chain Amyloidosis

Stanford California 94305

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Colorado

UPDATED

Denver Colorado

A Phase 3 clinical study for patients with TTR-mediated Amyloidosis

UPDATED

Denver Colorado

Patients are needed to participate in a clinical research study to evaluate Familial Amyloidotic Cardiomyopathy (FAC)

Aurora Colorado 80045

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Connecticut

New Haven Connecticut 06510

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

District of Columbia

UPDATED

Washington District of Columbia 20052

Patients are needed to participate in a clinical research study to evaluate Familial Amyloidotic Cardiomyopathy (FAC)

UPDATED

Washington District of Columbia 20422

Patients are needed to participate in a clinical research study to evaluate Familial Amyloidotic Cardiomyopathy (FAC)

Florida

Deerfield Beach Florida 33442

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Miami Florida 33136

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Georgia

Atlanta Georgia 30322

A Phase 1 clinical study for patients with Amyloidosis or Systemic Light-Chain Amyloidosis

Illinois

UPDATED

Chicago Illinois

A Phase 3 clinical study for patients with TTR-mediated Amyloidosis

UPDATED

Chicago Illinois

Patients are needed to participate in a clinical research study to evaluate Familial Amyloidotic Cardiomyopathy (FAC)

Chicago Illinois 60637

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Chicago Illinois 60637

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Chicago Illinois 60611

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

View More ▼

Chicago Illinois 60611

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Chicago Illinois

A clinical trial to evaluate treatments for patients with Relapsed or Refractory Systemic Light Chain Amyloidosis

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Oak Lawn Illinois 60453

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Oak Lawn Illinois 60453

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Oak Lawn Illinois 60453

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Indiana

UPDATED

Merrillville Indiana

Patients are needed to participate in a clinical research study to evaluate Familial Amyloidotic Cardiomyopathy (FAC)